More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications such as Ozempic have caused a loss of vision. At such a critical moment in ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide, the active ingredient in the drugs.

A 48-year-old from Suffolk County is one of over 30 people suing Ozempic's manufacturer for partial loss of vision.

People using Ozempic say they are losing their desire to drink. It’s anecdotal evidence right now, but this would be a game-changer for those who are trying to break free from addiction. Drugs like ...

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

But now, a growing number of lawsuits claim that Ozempic causes vision loss in some patients. RELATED: Ozempic and Wegovy May Have Landed 25,000 People in the ER—Here's the Scary Reason Why.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...